Caribou Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.55B +587.7% €274.39M -400.0% 17.8% +0.58 pp N/A N/A
    (estimated) €224.78M +785.6% -€91.46M -21.2% -40.7% +4.2 pp N/A N/A
    (estimated) €25.38M +27.3% -€116.00M -11.7% -457.0% +2.0 pp N/A N/A
    (estimated) €19.94M +136.1% -€131.30M -3.8% -658.3% +9.6 pp N/A N/A
    (estimated) €8.45M -2.0% -€136.52M +6.1% -1,615.7% -1.2 pp N/A N/A
    €8.63M -71.0% -€128.68M +46.1% -1,491.9% -12 pp -€115.06M +63.2% -1,334.0% -11 pp
    €29.75M +148.9% -€88.09M +2.7% -296.1% +4.2 pp -€70.49M -2.7% -236.9% +3.7 pp
    €11.95M +44.3% -€85.80M +48.6% -717.8% -0.21 pp -€72.42M +185.4% -605.8% -3.0 pp
    €8.28M -22.4% -€57.76M +95.1% -697.3% -4.2 pp -€25.37M -7.8% -306.3% -0.48 pp
    €10.67M +113.6% -€29.61M +46.4% -277.6% +1.3 pp -€27.53M +2.5% -258.1% +2.8 pp
    €5.00M -€20.22M -404.8% -€26.86M -537.7%

    Notifications